On this page
The short answer. SpaceX's June IPO sold about two thirds of the $114.2 billion of stock in the year's big US IPOs. At the November 16 close, 37 of the 52 sat below their IPO price.
Without SpaceX, the rest were worth about 22% less that day than at their IPO prices. These are past results; they leave out costs and taxes and do not predict future results. Anthropic, the maker of Claude, filed the third amendment to its IPO papers on November 17.
No shares can be sold until the SEC declares its registration effective and the deal is priced. The table shows how the year's priced IPOs have traded so far.
The biggest IPOs of 2026 in three numbers
Show the data
| Part | Value | Share |
|---|---|---|
| SpaceX | $75.0B | 65.7% |
| Cerebras Systems | $5.6B | 4.9% |
| Innio | $2.4B | 2.1% |
| Madison Air Solutions | $2.2B | 2.0% |
| Fervo Energy | $1.9B | 1.7% |
| Blackstone Digital Infrastructure Trust | $1.8B | 1.5% |
| Bending Spoons | $1.7B | 1.5% |
| Quantinuum | $1.7B | 1.5% |
| Forgent Power Solutions | $1.5B | 1.3% |
| The other 43 IPOs | $20.5B | 18.0% |
Biggest IPOs of 2026 list
The table holds the 52 companies worth $1 billion or more at their IPO price that listed in the US from January 1 to November 16, 2026. It shows what each sold, what it was worth, and where its shares closed on November 16.
The list runs in the order the deals priced. Value at IPO price counts all the shares that carry a stake in the company after the deal, times the IPO price. That basis matters, because many of this year's companies sold one class of stock while their owners kept another. Count only the class sold, and Arxis looks like a $1.8 billion company. With all its classes at $28 a share, it was worth about $11.3 billion.
Raised is the base deal, before the banks' option to buy extra shares, and it includes shares that old owners sold. StockTitan's guide to reading an S-1 walks through the filing that comes before a final prospectus.
| Company (ticker) | Exchange | Priced | IPO price | Raised | Value at IPO price | First-day close | Nov. 16 close | Change from IPO price |
|---|---|---|---|---|---|---|---|---|
| BitGo (BTGO) | NYSE | Jan. 21 | $18.00 | $213M | $2.08B | $18.49 | $3.86 | -78.6% |
| EquipmentShare (EQPT) | Nasdaq | Jan. 22 | $24.50 | $747M | $6.16B | $32.56 | $14.51 | -40.8% |
| Ethos Technologies (LIFE) | Nasdaq | Jan. 28 | $19.00 | $200M | $1.19B | $16.85 | $33.99 | +78.9% |
| PicS (PICS) | Nasdaq | Jan. 28 | $19.00 | $434M | $2.46B | $19.00 | $6.84 | -64.0% |
| York Space Systems (YSS) | NYSE | Jan. 28 | $34.00 | $629M | $4.32B | $33.61 | $4.92 | -85.5% |
| Bob's Discount Furniture (BOBS) | NYSE | Feb. 4 | $17.00 | $331M | $2.22B | $17.02 | $20.63 | +21.4% |
| Forgent Power Solutions (FPS) | NYSE | Feb. 4 | $27.00 | $1.51B | $8.22B | $29.00 | $20.57 | -23.8% |
| AGI (AGBK) | NYSE | Feb. 10 | $12.00 | $240M | $1.92B | $10.75 | $5.88 | -51.0% |
| SOLV Energy (MWH) | Nasdaq | Feb. 10 | $25.00 | $512M | $4.99B | $30.67 | $28.09 | +12.4% |
| Generate Biomedicines (GENB) | Nasdaq | Feb. 26 | $16.00 | $400M | $2.04B | $12.65 | $10.49 | -34.4% |
| MiniMed (MMED) | Nasdaq | March 5 | $20.00 | $560M | $5.62B | $18.49 | $18.65 | -6.8% |
| PayPay (PAYP) | Nasdaq | March 11 | $16.00 | $880M | $10.70B | $18.16 | $12.84 | -19.8% |
| Janus Living (JAN) | NYSE | March 19 | $20.00 | $840M | $5.14B | $23.60 | $32.10 | +60.5% |
| Madison Air Solutions (MAIR) | NYSE | April 15 | $27.00 | $2.23B | $13.20B | $31.75 | $22.37 | -17.1% |
| Arxis (ARXS) | Nasdaq | April 15 | $28.00 | $1.13B | $11.32B | $38.75 | $52.31 | +86.8% |
| AEVEX (AVEX) | NYSE | April 16 | $20.00 | $320M | $2.23B | $26.93 | $13.40 | -33.0% |
| Kailera Therapeutics (KLRA) | Nasdaq | April 16 | $16.00 | $625M | $1.98B | $26.00 | $12.57 | -21.4% |
| Alamar Biosciences (ALMR) | Nasdaq | April 16 | $17.00 | $191M | $1.13B | $22.00 | $30.55 | +79.7% |
| Yesway (YSWY) | Nasdaq | April 21 | $20.00 | $280M | $1.22B | $21.23 | $24.74 | +23.7% |
| X-Energy (XE) | Nasdaq | April 23 | $23.00 | $1.02B | $9.02B | $29.20 | $10.32 | -55.1% |
| HawkEye 360 (HAWK) | NYSE | May 6 | $26.00 | $416M | $2.42B | $34.00 | $18.51 | -28.8% |
| Fervo Energy (FRVO) | Nasdaq | May 12 | $27.00 | $1.89B | $7.66B | $36.54 | $10.98 | -59.3% |
| GMR Solutions (GMRS) | NYSE | May 12 | $15.00 | $479M | $3.35B | $13.98 | $11.72 | -21.9% |
| Cerebras Systems (CBRS) | Nasdaq | May 13 | $185.00 | $5.55B | $39.80B | $311.07 | $100.99 | -45.4% |
| Blackstone Digital Infrastructure Trust (BXDC) | NYSE | May 13 | $20.00 | $1.75B | $1.75B | $19.81 | $16.74 | -16.3% |
| EagleRock Land (EROK) | NYSE | May 13 | $18.50 | $320M | $2.41B | $21.84 | $20.58 | +11.2% |
| Lincoln International (LCLN) | NYSE | May 19 | $20.00 | $421M | $2.04B | $22.52 | $27.35 | +36.8% |
| Applied Aerospace & Defense (AADX) | NYSE | June 2 | $20.00 | $650M | $3.41B | $19.01 | $6.81 | -66.0% |
| Innio (INIO) | Nasdaq | June 3 | $27.00 | $2.43B | $20.25B | $33.30 | $13.82 | -48.8% |
| Quantinuum (QNT) | Nasdaq | June 3 | $60.00 | $1.68B | $15.66B | $60.38 | $31.75 | -47.1% |
| Liftoff Mobile (LFTO) | Nasdaq | June 3 | $23.00 | $437M | $3.83B | $28.45 | $24.46 | +6.3% |
| Sunshine Silver Mining & Refining (SSMR) | NYSE | June 3 | $13.50 | $270M | $1.90B | $17.15 | $12.67 | -6.1% |
| ERock (EROC) | NYSE | June 9 | $21.50 | $600M | $4.72B | $18.75 | $7.49 | -65.2% |
| Parabilis Medicines (PBLS) | Nasdaq | June 9 | $20.00 | $670M | $2.36B | $31.60 | $28.45 | +42.2% |
| SpaceX (SPCX) | Nasdaq | June 11 | $135.00 | $75.00B | $1.77T | $160.95 | $137.36 | +1.7% |
| Kardigan (KARD) | Nasdaq | June 17 | $16.00 | $400M | $1.43B | $22.00 | $12.85 | -19.7% |
| DPC Holdings (DPC) | NYSE | June 24 | $33.00 | $919M | $4.79B | $46.88 | $31.80 | -3.6% |
| Sinda (SIND) | NYSE | June 25 | $12.00 | $213M | $1.79B | $12.00 | $11.92 | -0.7% |
| Bending Spoons (BSP) | Nasdaq | June 30 | $29.00 | $1.68B | $9.42B | $40.50 | $40.98 | +41.3% |
| ITG (ITG) | Nasdaq | June 30 | $16.00 | $312M | $1.94B | $17.71 | $5.68 | -64.5% |
| Lime (LIME) | Nasdaq | June 30 | $25.00 | $174M | $1.60B | $26.00 | $20.18 | -19.3% |
| Csquare (CSQR) | NYSE | July 15 | $21.00 | $1.05B | $3.26B | $20.67 | $16.55 | -21.2% |
| Standard Nuclear (STDN) | NYSE | July 15 | $15.00 | $150M | $2.41B | $12.30 | $9.33 | -37.8% |
| Jersey Mike's Subs (JMKE) | NYSE | July 29 | $23.00 | $1.00B | $7.31B | $21.63 | $19.21 | -16.5% |
| Braveheart Bio (BRVE) | Nasdaq | Aug. 5 | $18.00 | $382M | $1.32B | $29.80 | $19.49 | +8.3% |
| Latigo Biotherapeutics (LTGO) | Nasdaq | Aug. 6 | $18.00 | $346M | $1.14B | $18.25 | $12.60 | -30.0% |
| Londian Wason New Energy Tech (FOIL) | NYSE | Aug. 11 | $22.00 | $94M | $1.72B | $24.50 | $15.42 | -29.9% |
| Lyntris (LYNX) | NYSE | Aug. 18 | $17.50 | $298M | $2.03B | $15.01 | $12.90 | -26.3% |
| American Savings Bank (ASBH) | NYSE | Sept. 15 | $16.00 | $129M | $1.04B | $17.00 | $21.94 | +37.1% |
| Orion180 Insurance Group (OIG) | Nasdaq | Sept. 17 | $12.00 | $240M | $1.19B | $11.66 | $10.43 | -13.1% |
| ADARx Pharmaceuticals (ADRX) | Nasdaq | Sept. 24 | $17.00 | $446M | $1.82B | $19.35 | $14.00 | -17.6% |
| Accelevation Holdings (ACCV) | Nasdaq | Sept. 29 | $18.00 | $540M | $4.05B | $17.95 | $11.25 | -37.5% |
Source: each company's final prospectus on SEC EDGAR (Form 424B4, or 424B1 for PicS and AGI) for the IPO price, the shares sold and the shares outstanding; for American Savings Bank, which filed with its bank regulator, its pricing release and the 64,998 thousand weighted-average shares in its third-quarter 2026 release, unchanged by an IPO in which only existing holders sold. StockTitan data for the official closes of the first day and of November 16, 2026. Priced is the prospectus or release date, or the trading day before the first trade where neither gives one. Base deals, before the underwriters' option. Changes from the IPO price are past results; they leave out costs and taxes and do not predict future results.
How have 2026 IPOs performed?
Most did well on their first day and then slipped. At the November 16 close, 37 of the 52 were below their IPO price.
The first day went well for most of them, with 35 of the group closing above the IPO price. The months after told a different story. Of those 35, 21 were below their IPO price at the November 16 close. Across all 52, the median stock sat 19.7% under its IPO price that day.
A few went the other way. Arxis closed November 16 86.8% above its $28 IPO price, the best of the group, and Alamar Biosciences and Ethos Technologies were each up close to 80%. These and the figures above are past results; they leave out costs and taxes and do not predict how any IPO will trade.
Two prices matter for anyone who bought. Investors given shares in the offering paid the IPO price, set the evening before trading. Buyers on the exchange paid market prices from the next day on, so the same stock can look different to each. The SpaceX section below shows that gap.
SpaceX IPO, the largest of the year
SpaceX sold $75.0 billion of stock in June. That one deal was about two thirds of all the money the 52 large IPOs raised this year.
SpaceX's final prospectus set the price at $135 a share, and the stock lists on Nasdaq and Nasdaq Texas as SPCX. At that price, the whole company was worth about $1.77 trillion.
The shares sold were a thin slice of that, about 4.2% of all the shares. Even so, the $75.0 billion was more than the other 51 large IPOs raised together.
Its first day ended at $160.95. On November 16 it closed 1.7% above its IPO price but 14.7% below that first-day close, so an IPO buyer and a first-day buyer saw the same stock very differently.
SpaceX also dominates the group's combined value. Add up every company's value, and the group was worth about 1% less on November 16 than at the IPO prices. Leave SpaceX out, and the other 51 were worth about 22% less. These and SpaceX's figures above are past results; they leave out costs and taxes and do not predict future results.
How many IPOs in 2026?
June alone had 14 of the year's IPOs worth $1 billion or more. None priced from October 1 to November 16.
Show the data
| Category | Value |
|---|---|
| Jan | 5 |
| Feb | 5 |
| Mar | 3 |
| Apr | 7 |
| May | 7 |
| Jun | 14 |
| Jul | 3 |
| Aug | 4 |
| Sep | 4 |
| Oct | 0 |
| Nov 1-16 | 0 |
The year built up to June. January and February had five large IPOs each. April and May had seven each, and June had 14, SpaceX among them. After that the pace slowed to three or four a month.
The last IPO worth $1 billion or more priced on September 29, when Accelevation Holdings sold shares at $18. In the seven weeks after it, no IPO reached the line. Lycia Therapeutics came closest, at about $0.99 billion. Smaller IPOs are not in the table.
Direct listings and SPACs in 2026
Direct listings have no IPO price, so there is nothing to measure them from. SPACs do raise money in an IPO, but they are shell companies with no business yet. Both are counted apart from the table.
In a direct listing, old owners sell on the exchange and no bank sets a price first. Ionic Digital's prospectus says there is "no price at which underwriters initially sell shares to the public." In 2026, 17 companies filed a final prospectus for a direct listing, listed below.
A SPAC, or blank-check company, raises cash in its own IPO and later merges with a private business. From January 1 to November 16, 154 of them filed a final IPO prospectus on SEC EDGAR.
Two more kinds of new stock are left out. SK hynix sold about $26.5 billion of American depositary shares, certificates that stand for a foreign company's stock, on Nasdaq in July, at $149 per depositary share. Its final prospectus says each one represents one tenth of a common share, and its stock already traded in Korea. Spin-offs such as FedEx Freight came out as shares handed to the parent company's owners.
Show the data
| Direct listing (ticker) | Final prospectus filed |
|---|---|
| Virtuix Holdings (VTIX) | Jan. 26 |
| Polaryx Therapeutics (PLYX) | Feb. 2 |
| Braiin (BRAI) | Feb. 2 |
| TG-17, known as Bond (OBAI) | Feb. 3 |
| FreeCast (CAST) | March 4 |
| The Metals Royalty Company (TMCR) | April 8 |
| Lakewood-Amedex Biotherapeutics (LABT) | April 23 |
| Conexeu Sciences | May 11 |
| AIAI Holdings (AIAI) | May 14 |
| Amass Brands (AMSS) | May 18 |
| QumulusAI (QMLS) | July 15 |
| Ionic Digital (IOND) | July 28 |
| Game Your Game (GYGY) | July 29 |
| Advasa Holdings (ADBT) | Aug. 12 |
| First Breach (FBDT) | Aug. 20 |
| Roze AI (RZAI) | Sept. 28 |
| Georgia Banking Company (GBC) | Oct. 29 |
Source: SEC EDGAR full-text search of 2026 final prospectuses (Form 424B4) through November 16, 2026, for direct listings and for blank-check companies (industry code 6770); SK hynix final prospectus.
Anthropic IPO filing
Anthropic, the maker of Claude, has filed to list on Nasdaq under the ticker ANT. Its IPO has not priced and no final prospectus has been filed, so it is not in the table.
- S-1 filed On October 26, 2026, Anthropic filed its registration statement with the SEC.
- Price range Amendment No. 2 on November 10 set a range of $70 to $78 a share for 825 million Class A shares.
- Amendment No. 3 On November 17 the filing said the stock had been approved for listing on Nasdaq under the symbol ANT.
- Final price In any IPO, the SEC first declares the registration statement effective; the company and its banks then set the price and file a final prospectus.
- First trade Trading on the exchange starts after the price is set.
Anthropic's second amendment of November 10 set a price range of $70 to $78 a share for 825 million Class A shares. Its third amendment, filed November 17, says the stock has been approved for listing on the Nasdaq Global Select Market under the symbol ANT. No shares can be sold until the SEC declares the registration statement effective and the offering is priced.
SpaceX's $75.0 billion is the largest IPO of 2026 in the table, which counts only IPOs that have priced and filed a final prospectus. StockTitan's earlier coverage reports the price range set out in Amendment No. 2 and walks through the first S-1 filing.
What to watch
- Anthropic's final terms: the final prospectus (Form 424B4) on SEC EDGAR, filed once the registration statement is effective and the offering is priced.
Our numbers
These figures are our calculations from the sources linked in this article. The stocks have traded for different lengths of time, about ten months for January's deals and seven weeks for late September's.
- 52 US IPOs worth $1 billion or more, January 1 to November 16, 2026: each IPO's shares that carry a stake in the company after the deal, times the IPO price, before the banks' option.
- Arxis at about $11.3 billion, against $1.8 billion on its Class A shares alone: its Class A and Class B shares after the deal, then its Class A shares alone, times $28.
- 37 of 52 below their IPO price, median 19.7% below: each November 16 close against the IPO price, every close matched to a second price history.
- $114.2 billion of stock sold, 65.7% of it by SpaceX: the base deal of each IPO, added up.
- 35 first-day risers, 21 of them below their IPO price by November 16: first-day and November 16 closes against the IPO price.
- SpaceX 14.7% below its first-day close on November 16: $137.36 against $160.95.
- About 1% less value for all 52 and about 22% less without SpaceX: each IPO's share count times the November 16 close, against the same count times the IPO price.
- About $1.77 trillion for SpaceX at $135, with about 4.2% of its shares sold: its 13,075,865,175 shares after the deal, and the 555,555,555 it sold.
- No IPO of $1 billion or more priced from October 1 to November 16, with Lycia Therapeutics closest at about $0.99 billion: every final prospectus of that span outside SPACs, valued the same way.
- 17 direct listings and 154 SPAC IPOs: separate companies in SEC EDGAR full-text searches of 2026 final prospectuses.
Frequently asked questions
From January 1 to November 16, 2026, 52 companies worth $1 billion or more at their IPO price went public on Nasdaq or the NYSE. Over the same weeks, 154 blank-check companies, or SPACs, filed final IPO prospectuses, and many smaller companies listed too.
SpaceX, by far. It sold $75.0 billion of stock at $135 a share on June 11, 2026, which valued the whole company at about $1.77 trillion. Cerebras Systems came second by money raised, at $5.55 billion.
Among the large ones are SpaceX, Cerebras Systems, Innio, Madison Air Solutions, Fervo Energy, Quantinuum, Bending Spoons, Jersey Mike's Subs and PayPay. The full list, with prices and dates, is in the table above.
At the November 16, 2026 close, 37 of the 52 large IPOs were below their IPO price and 15 were above it. The median one was 19.7% below. These are past results; they leave out costs and taxes and do not predict future results.
As of November 17, 2026, Anthropic's filings set no date and no final price has been filed. Its Amendment No. 3, filed that day, says the stock has been approved for listing on Nasdaq under ANT, with a range of $70 to $78 a share. No shares can be sold until the SEC declares the registration statement effective and the offering is priced; the final price then appears in the final prospectus (Form 424B4).
Sources
- StockTitan: Anthropic IPO price range
- StockTitan: Anthropic S-1 guide
- StockTitan: S-1 filings explained
- American Savings Bank: pricing of its initial public offering
- American Savings Bank: third-quarter 2026 results
- SpaceX final prospectus (Form 424B4)
- Cerebras Systems final prospectus (Form 424B4)
- Arxis final prospectus (Form 424B4)
- Accelevation Holdings final prospectus (Form 424B4)
- Ionic Digital final prospectus (Form 424B4)
- SK hynix final prospectus (Form 424B4)
- Anthropic Form S-1/A, Amendment No. 2
- Anthropic Form S-1/A, Amendment No. 3
- SEC EDGAR full-text search